Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis
Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis
This development represents an important step in addressing mental health and behavioral health challenges in the community. The initiative focuses on improving access to quality care and supporting those in need of mental health services.
[Psychedelic Therapy News]